Hemopatch™ 在预防胰体尾切除术后胰瘘中的有效性。
The effectiveness of Hemopatch™ in preventing postoperative distal pancreatectomy fistulas.
机构信息
a Department of General Surgery , A.O.R.N. "A. Cardarelli" , Naples , Italy.
b Department of General Surgery , Public Hospital "Sant'Andrea" , La Spezia , Italy.
出版信息
Expert Rev Med Devices. 2019 Mar;16(3):253-256. doi: 10.1080/17434440.2019.1582328. Epub 2019 Feb 26.
OBJECTIVES
Postoperative fistula after distal pancreatectomy (DP) is still a significant complication, although many tools and tips have been utilized to try to reduce its elevated frequency. This paper focuses on the role of a sealing hemostatic device, Hemopatch™, to prevent postoperative pancreatic fistula (POPF) after DP.
METHODS
Retrospectively we divided our sampling of 57 patients submitted to DP into two groups according to the availability of the device: 18 patients without Hemopatch™ and 39 patients using Hemopatch™.
RESULTS
Significant difference was observed in leak occurrence (p < 0.05). No significant association was observed between the number of blood transfusions, the frequency of postoperative complications, associated splenectomy and POPF.
CONCLUSION
This is a preliminary study and the first focused on the prevention of POPF after DP using Hemopatch™. Thanks to its double function of hemostasis and sealant, Hemopatch™ can be taken into consideration as an efficacy tool to prevent pancreatic POPF.
目的
尽管已经采用了许多工具和技巧来尝试降低远端胰腺切除术（DP）后瘘管的发生率，但术后瘘管仍然是一个严重的并发症。本文重点关注一种名为 Hemopatch™ 的密封止血装置在预防 DP 后胰瘘（POPF）中的作用。
方法
回顾性地，我们根据该装置的可用性将 57 名接受 DP 的患者分为两组：18 名未使用 Hemopatch™的患者和 39 名使用 Hemopatch™的患者。
结果
在漏出的发生方面观察到显著差异（p < 0.05）。输血量、术后并发症的频率、联合脾切除术与 POPF 之间无显著相关性。
结论
这是一项初步研究，也是首次聚焦于使用 Hemopatch™预防 DP 后 POPF。由于其止血和密封的双重功能，Hemopatch™可以被视为预防胰腺 POPF 的有效工具。
Zotero 插件